Ruthenium complexes used as a regulator of nitric oxide profiles and decrease nitrosylated heme proteins in models of acute and delayed cardiac transplant rejection [J]. J Cardiovasc Pharmacol, Moncler Mont, 2002, 39 (3): 441-448. [18] Mosi R, Seglin B, C., ~-neron B, UGG Australia España, et al. Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger [J]. Biochem Biophys Res Commun, 2002, 292 (2): 519-529. [19] Bergamo A, Zorzet S, Gava B, UGGs online outlet, et al. Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells [J]. Anticancer Res, 2000, 11 (8): 665-672. [20] Morbidelli L, Donnini S, Filippi S, et al. Antiangiogenic properties of selected ruthenium (III) complexes that are nitric oxide scavengers [J]. Br J Cancer, 2003, 88 (9): 1484-1491. [21] Ravem M, Bamex~S, Cassino C, et al. Appraisal of the redox behavior of the antimetastatic ruthenium (III) complex [ImH][trans-RuCl5(DMSO-S)(H2O)] NAMI.A [J]. Dalton Trans, 2004, Moncler France, 15 (2): 2347-2351. [22] Alessio E, Mestroni G, Bergamo A, et al. Ruthenium antimetastatic agents [J]. Curr Top Med Chem, 2004, 4 (15): 110-115. [23] Bouma M, Noorden B, Jansen MT, et al. Development of an LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI.A [J]. J Pharm Biomed Anal, 2003, 31 (2): 215-228. [24] Bergamo A, Gava B, Alessio E, et al. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity [J]. Int J Oncol, 2002, 21 (6): 1331-1336. [25] Chen Y, Shepherd RE. Ru2(tth)(H2O) as a rapid NO scavenger (ttha6- = triethylenetetraminehexa - acetate) [J]. J Inorg Biochem, 1997, 68 (3): 183-193. [26] Kowaluk EA, Seth P, Canada Goose Jakke, Fung HL. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle [J]. J Pharmacol Exp Ther, 1992: 262 (3): 916-922.